It was recently demonstrated that NAMPT inhibition attenuates glyceraldehydes-3-phosphate dehydrogenase activity, which in turn affects glycolysis, the pentose phosphate pathway, and the TCA cycle and their downstream pathways in cancer cells [1]. Here, GAPDH is linked to cancer.